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ABSTRAK 
TAJUK: Kajian mengenai Pengatahuan, Sikap dan Amalan terhadap Saringan 
Kanser Kolorektal Dikalangan Pesakit Melayu berisiko sederhana di Klinik 
Kesihatan Selising. 
 
PENGENALAN: Di Asia, kanser kolorektal sedang meningkat secara mendadak. Di 
sebalik peningkatan dari segi insiden dan mortaliti, kadar saringan kanser kolorektal masih 
rendah di kebanyakan negara-negara Asia.  Penerimaan untuk melakukan saringan kanser 
kolorektal dipengaruhi oleh pengetahuan dan sikap manusia. Kajian ini adalah bertujuan 
untuk menilai tahap pengetahuan, sikap dan amalan dikalangan pesakit Melayu terhadap 
saringan kanser kolorektal.     
 
OBJEKTIF: Objektif kajian ini adalah untuk mengenal pasti tahap pengetahuan, sikap 
dan amalan, serta faktor-faktor yang berkaitan dengannya, dikalangan pesakit Melayu 
berisiko sederhana terhadap ujian saringan kanser kolorektal. Selain itu, kajian ini juga 
bertujuan untuk mengenalpasti hubungan diantara pengetahuan dan sikap, serta 
pengetahuan dan amalan terhadap saringan kanser kolorektal. 
 
METODOLOGI: Ianya adalah kajian keratan rentas yang dijalankan bermula Oktober 
2009 sehingga Disember 2009 di Klinik Kesihatan Selising. Kajian ini menggunakan 
borang soal selidik yang memerlukan peserta menjawab sendiri soalan tersebut. Ianya 
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melibatkan 262 peserta Melayu berumur 50 tahun dan ke atas. Soalannya terdiri daripada 
tiga bahagian yang melibatkan pengetahuan, sikap dan amalan  terhadap saringan kanser 
kolorektal. 
 
KEPUTUSAN: Keputusan daripada kajian ini menunjukan hanya 6.1% daripada 
responden mempunyai pengetahuan yang baik dan 31.7% daripada responden mempunyai 
sikap yang baik terhadap saringan kanser kolorektal. Seterusnya, kadar saringan kanser 
kolorektal adalah teramat rendah dikalangan responden dimana hanya dua daripada 262 
responden telah menjalani ujian saringan kanser kolorektal. Selain itu, keputusan kajian ini 
juga menunjukan terdapatnya hubungan(korelasi) diantara pengetahuan dan sikap terhadap 
saringan kanser kolorektal. Seterusnya, kajian ini juga menunjukkan bahawa lelaki, tahap 
pendidikan yang rendah dan jenis pekerjaan bukan profesional  adalah faktor-faktor yang 
mempengaruhi tahap pengetahuan terhadap saringan kanser kolorektal.  
 
KESIMPULAN: Keputusan dari kajian ini menunjukan responden Melayu yang berisiko 
sederhana mempunyai pengetahuan yang tidak mencukupi, sikap dan amalan yang kurang 
memuaskan terhadap saringan  kanser kolorektal. Ianya juga menunjukan bahawa dengan 
peningkatan pengetahuan akan mengurangkan sikap yang negatif terhadap saringan kanser 
kolorektal. Selain itu, didapati tahap pendidikan yang rendah adalah faktor yang 
menentukan tahap pengetahuan dan sikap, manakala jenis pekerjaan pula mempengaruhi 
tahap pengetahuan dan amalan terhadap saringan kanser kolorektal. 
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ABSTRACT 
TITLE: A STUDY ON KNOWLEDGE, ATTITUDE AND PRACTICE ON 
COLORECTAL CANCER SCREENING AMONG AVERAGE RISK MALAY 
PATIENTS ATTENDING SELISING HEALTH CLINIC 
 
INTRODUCTION: Colorectal cancer is rapidly increasing in Asia. Despite the rising 
trend in incidence and mortality, colorectal cancer screening rates are still low in most 
Asian countries. The acceptability of CRC screening is influenced by people’s knowledge 
and attitude. This study was conducted to evaluate the knowledge, attitude and practice of 
Malay people toward CRC screening. 
 
 OBJECTIVES: The objectives of the study are to determine the level of knowledge, 
attitude, practice and their associated factors on colorectal cancer screening among average 
risk Malay patients. It also to determine the relationship between knowledge and attitude 
score, and knowledge and practice score on colorectal cancer screening. 
 
METHODOLOGY: It was a cross sectional study conducted from October 2009 to 
December 2009  at Selising Health Clinic. The study used a self administered 
questionnaire which involved 262 Malay participants aged 50 years and above. The 
questionnaire consisted of 3 parts, which dealt with knowledge, attitude and practice on 
colorectal cancer and screening.   
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RESULTS: There were only 6.1% respondents had good knowledge and 31.7% of the 
respondents had good attitudes on colorectal cancer screening. Consequently, colorectal 
cancer screening uptake was extremely poor with only two out of 262 of the respondents 
had CRC screening. There was moderate to good positive correlation between knowledge 
and attitude score. In addition, the results  show male gender, low education level and non 
professional group are the associated factors for low level of knowledge on colorectal 
cancer screening. 
 
CONCLUSION:  These findings indicate that average risk Malay patients had inadequate 
knowledge, poor attitude on colorectal cancer screening together with extremely poor 
practice on colorectal cancer prevention. This study also concluded that increasing 
knowledge on colorectal cancer screening may encourage less negative attitudes about 
colorectal cancer screening. Other than that, educational level appears to be the major 
determinant on the level of knowledge and attitudes. While, type of occupation affects the 
level of knowledge and practice on colorectal cancer screening.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Epidemiology of colorectal cancer 
Colorectal cancer (CRC) is a worldwide problem, with an annual incidence of 
approximately one million cases and an annual mortality of more than 500,000 
worldwide(WHO, 2003).  In the United States and other Western countries, colorectal 
cancer ranks the fourth most common malignant neoplasm and the second leading 
cause of death(Ahmedin et al., 2008). During the last decades, there was a dramatic 
increase in the incidence of colorectal cancer in Asia. Moreover, data from this region 
indicates that this incidence had already approximates those reported from the West, 
especially among the more affluent populations(Sung et al., 2008). 
 
In Peninsular Malaysia, colorectal cancer is the first among male and the second most 
common among female after breast cancer. In 2006, there were 2866 cases of colorectal 
cancer which represented 13.2 % of all cases registered with National Cancer Registry. 
The incidence was highest among Chinese with age-standardized rates was  21.4/100 
000 population and were lower in Indian and Malay where the age-standardized rates  
were 11.3/100 000 and 9.5/100 000 respectively(MOH, 2006). 
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1.2 Risk factors 
At present, the cause of colorectal cancer is not completely understood. However, it is 
thought to involve many factors developing over a long period of time. The risks for 
colorectal cancer vary from country to country and even within countries and also 
among individual based on diet, lifestyle and hereditary factors.  
 
Migrant studies which was among one or two generations of  immigrants moving from 
low-incidence of colorectal cancer countries to host countries of high incidence showed 
they have a higher burden from colorectal cancer(Melissa et al., 2007). It was 
concluded that acquired environmental and lifestyle factors including a diet low in fiber 
and vegetables but high in fat, red meat and alcohol, sedentary occupation and cigarette 
smoking   could be the major modifiable etiologic causes.  
 
Among non modifiable  risk factors for colorectal cancer include age more than 50 
years old, a family history of colorectal cancer, a personal history of colorectal cancer 
and adenoma, a hereditary history non polyposis colorectal cancer syndrome, Turcot’s 
syndrome, Gardner’s syndrome or inflammatory bowel disease of the colon such as 
ulcerative colitis and Crohn’s disease.  
 
 
 
3 
 
The population age of more than 50 years is the only risk factor considered to be of 
"average risk," whereas those with other risk factors such as personal or family history 
of colorectal cancer, adenomas or inflammatory bowel disease are considered to be at 
"high risk”. Approximately 70 to 80 % of CRC’s arises among population at the 
average risk(U.S.Preventive Services Task Force, 2008). 
 
1.3 Pathogenesis of colorectal cancer 
Colorectal cancer is a genetic disorder which can be acquired or inherited. The 
inherited syndromes only accounts for less than 5% of all colorectal cancer cases. 
Therefore, majority of the cases (95%) are often considered sporadic(Burt et al., 1995).  
 
According to genetic model, colorectal cancer develops through a process termed 
multistep carcinogenesis in which progressive genomic instability affects the function 
of genes that are important in oncogenesis which includes oncogenes (K-ras), tumor 
suppressor genes (APC, DCC/DPC4, P53), DNA mismatch repair genes (hMLH1 and 
hMLH2), cell adhesion molecules (epCam), angiogenic factors (VEGF), as well as 
epigenetic changes (DNA menthylation) and microsatellite instability(Burt et al., 
1995). 
 
The development of colorectal cancer occurring in stages result in transformation of a 
normal epithelial cell into adenocarcinoma. The abnormal colonocytes with certain 
genetic alterations was able to proliferate excessively. As this process continues, the 
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cells assume malignant characteristics of invasiveness and metastatic potential.  In 
addition to genetic predisposition, environmental factors are believed to be associated 
with an increased colorectal cancer risk(Pignatelli et al., 2008). 
 
Colorectal cancer is a slow growing disease that may present without symptoms for 
several years. In most of the cases, cancer of the colon and rectum arise from the 
formation of a small, non cancerous growth called polyps. These polyps, or 
precancerous lesions, are an early warning sign that colorectal cancer may develops. 
The average time from onset of a polyp to onset of carcinoma, termed the "dwell time," 
is about ten to fifteen years. However, dwell time appears to vary with the location of 
the cancer. It is longer in the distal colon than in the proximal colon, and it is shortest in 
the recto sigmoid segment(Launoy et al., 1997).  
 
1.4 Clinical Manifestation 
The key clinical features of large bowel cancers are alteration in bowel habit and per 
rectal bleeding. The presenting signs and symptoms are also influenced by the location 
of the tumor. If it occurs at the caecum and ascending colon, usually it presented late 
with palpable mass, right iliac fossa discomfort or hypochromic microcytic anemia due 
to  chronic occult blood loss. Since the left colon is narrower and holds more solid 
content compared to right colon, the obstruction, alteration of bowel habit and perectal 
bleeding are common presentation. While if the tumor is in the rectum, bleeding is 
often the main symptom and the patient may believe that he has piles. A feeling of 
incomplete evacuation of the rectum is common after defecation and the patient may 
5 
 
experience urgency and the frequent passage of slime and blood. As the rectum is 
capacious, obstruction is unusual(Forrest et al., 1995).  
 
1.5 Prognosis 
The outcome of colorectal cancer depends on how advanced the disease when it was 
first diagnosed. Therefore, the diagnosis of early stage cancer results in better survival. 
Curtbert Dukes described a pathological staging system for colorectal cancer based on 
invasion through the bowel wall and lymph nodes involvement.  It has major 
prognostic implications. In early stages (Dukes A-invasion of muscularis propia), 
survival is excellent through surgical intervention with 62% to 98% of 5 years survival. 
While in those presenting late (Dukes C- Lymph nodes involvement) the chances of 
cure is less than 30%(David et al., 2008). 
 
Apart from that, the TNM classification according to the American Joint Committee on 
Cancer (AJCC) and the Union Internationale Contre le Cancer (UICC) which depends 
on the depth of cancer invasion into the bowel wall, lymph nodes involvement and 
distant metastasis showed a correlation between stage at diagnosis and survival. For 
stage 0 and 1, the survival rate was up to 100% while in stage 4, it was only 3%(Paul et 
al., 2006).  
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However, earlier symptomatic diagnosis was difficult to achieve since majority of them 
were asymptomatic at early stage, even if this could be achieved, the overall 
improvement in survival was likely to be small. Therefore, screening is the option to 
detect CRC during its pre symptomatic phase which results in improvement of the 
survival rate.  
 
1.6 Treatment 
 
The treatment for colorectal cancer depends on the stage of the cancer. At early stage, it 
was almost curable. However, when it was detected at a late stage with distant 
metastases, it was less likely to be curable. 
 
 
Surgery is the mainstay of treatment for colorectal cancer as it offers a higher chance of 
cure. Surgical resection with anastomosis is the treatment of choice in more than 85% 
of patients with colon cancer while locoregional resection is for rectal cancer.  The 
majority of resections  done with curative intent where the affected segment bearing 
tumor is first resected with adequate margins of normal appearing tissue together with 
its vascular pedicle and lymphatic drainage, then an anastomosis or colostomy is 
performed. In case of multiple metastases, palliative (noncurative) resection of the 
primary tumor is still offered to reduce further morbidity caused by tumor bleeding, 
invasion or obstruction(Paul et al., 2006). 
 
 
7 
 
Chemotherapy is used to reduce the likelihood of metastasis developing, shrinking 
tumor size or slowing tumor growth. Chemotherapy is often applied after surgery 
(adjuvant), before surgery (neoadjuvant), or as the primary therapy (palliative). In 
colon cancer, usually chemotherapy after surgery is given only if the cancer has spread 
to the lymph nodes (Stage III)(Paul et al., 2006). 
 
 
Radiotherapy is not used routinely in colon cancer, as it could lead to radiation enteritis 
and it is difficult to target specific portions of the colon. It is more common to be used 
in rectal cancer, since the rectum does not move as much as the colon and is thus easier 
to target(Paul et al., 2006).  
 
1.7 Colorectal cancer screening 
The American Cancer Society has recommended people aged more than 50 years to 
undergo CRC screening as most of sporadic CRCs in developed countries occur in 
patients above 50 years old. CRC screening test enables early detection and cure of 
early-stage disease cost effectively. Individuals who undergo regular FOBT are shown 
to have significant reduction in CRC mortality(Kronborg et al., 1996; Mandel et al., 
2000). Further reduction can be achieved by performing sigmoidoscopy and 
colonoscopy followed by colonoscopic polypectomy. However many studies showed 
the obstacle for implementing CRC screening program were  limited by knowledge on 
CRC, inconvenient and embarrassing nature of the test and lack of physician 
recommendation. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1. Risks factors 
Notwithstanding, the important of age and genetic influences which are non modifiable 
risk factors, several lines of evidence support the substantial role of lifestyle or 
environmental factors in the etiology of colorectal cancer. By knowing the risk factors 
for colorectal cancer, it may motivate and remove barriers for colorectal screening. 
 
2.1.1 Non modifiable risk factors 
2.1.1.1 Age 
The single greatest risk factor for development of CRC is advancing age. The incidence 
of the colorectal cancer increases exponentially with age and become plateaus in the 
sixth decade. Thus, ninety percent of colorectal cancer occurs at the age of above 50 
years old and peak at the age of 60 years(Jaffer et al., 2005).  However, only 5% of 
cases reported in those under the age of 40 years old.  Colorectal cancer is also 
common in men and this is true of all countries and races(Reis et al., 2007).  Recent 
data from National Cancer Registry showed similar finding among Malaysian 
population where more than half of the total cases reported at the aged 60 years and 
above(Radzi et al., 2009). More males were recorded compared to females. Due to the 
estimated 10 year timescale for the adenoma-carcinoma sequence, most experts agree 
that screening should target those over 50 years(Radzi et al., 2009). 
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2.1.1.2 Familial risk factors   
Colorectal cancer is the most familial of all human cancers. Between 10% to 30% of 
colorectal cancer patients have a family history of colorectal cancer but do not belong 
to a known inherited syndrome(Burt, 1996). First-degree relatives of persons with 
colorectal cancer have a twofold to threefold increase in the risk of colorectal cancer in 
comparison with control or population incidence(Johns and Houlstan, 2001). Moreover, 
the risk increases with the number of relatives with colorectal cancer, the closer the 
relatives are to the patient, and with the age of colorectal cancer in family 
members(Burt, 1996).  
 
There are several conditions which have a significant predisposition for colorectal 
cancer. The first is Familial Adenomatous Polyposis (FAP)  responsible for 0.5% to 1% 
of all colorectal cancer(Rustgi, 1994). Genetically, FAP is an autosomal dominant 
condition caused by APC (adenomatous polyposis coli) gene mutations of tumor  
suppressor gene on chromosome 5q21(Kinzler et al., 1991). Spontaneous mutations 
account for approximately 20% of cases in which no prior family history is 
present(Hamilton, 1993). Persons with FAP develop hundreds to thousands of colon 
polyps in adolescence, and nearly in all patients with untreated FAP there is malignant 
transformation in at least one of these polyps by the fifth decade. The incidence of 
malignancy in these cases approaches 100%(Strate and Syngal, 2005). Gardner's 
syndrome is a phenotypic variant of FAP. In addition to colonic polyposis, other 
manifestations may be seen, such as benign soft tissue tumors, osteomas, duodenal 
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adenomas, periampullary tumors, desmoids tumors and congenital hypertrophy of the 
retinal pigment epithelium.  
 
The other condition is hereditary non polyposis colorectal cancer (HNPCC) or Lynch 
syndrome. HNPCC is the most common inherited disorder accounting for 2% to10% of 
colon cancer cases and lifetime risk of 80%. It is characterized by the development of 
colorectal cancer and an increased susceptibility to numerous other cancers. HNPCC is 
also an autosomal dominant inherited disorder and is caused by a mutation in one of the 
mismatch repair genes (MLH1, MSH2, MSH6 or PMS2)(Haq et al., 2008). Persons 
with Lynch I syndrome develop a small number of proximal polyps at the young age, 
which often progressed rapidly to the development of colon cancers. Persons with 
Lynch II syndrome develop the characteristics of Lynch I syndrome together with extra 
colonic cancers such as endometrial, ovarian, small bowel, transitional cell of the ureter 
or bladder, and gastric cancer. 
 
In Malaysia, there was no accurate data available on prevalence of hereditary colon 
cancer, since there was no customized registry exists to collect such information. Thus, 
the burden of the disease could not be estimated in our community.  But, making the 
diagnosis of hereditary form of colon cancer is important not just for the individual but 
also for the sake of other family members who may be affected.  In these conditions, 
screening plays an important role to detect the lesion earlier before cancer develops.  
 
11 
 
Another endogenous factor associated with an increased risk of colorectal cancer is 
inflammatory bowel disease.  Early studies of patients with Crohn’s disease and 
ulcerative colitis demonstrated a risk of 20 to 30 times the average population 
risk(Jaffer et al., 2005). Chronic and extensive inflammatory bowel disease (IBD), 
which therefore leads to an increased turnover of epithelial cells, is associated with an 
increased risk for bowel cancer. The risk is greater for ulcerative colitis than for 
Crohn’s colitis. Moreover, it become more great with the longer the duration of the 
disease, which is more than eight years and more extensive the area of inflammation, 
which is more than rectosigmoid. However, with intensive and systematic medical 
therapy and earlier surgery, the cancer risk and mortality from colorectal cancer have 
decreased(Paul et al., 2006). 
 
2.1.2 Modifiable risk factors 
2.1.2.1 Diet 
International variations in diet and colorectal cancer rates from one country to another 
 
suggest that diet is an important preventable risk factor for
 
colorectal cancer. The 
dietary recommendations to reduce gastrointestinal cancer risk include lowering fat 
intake, avoidance of grilled and smoked foods and increasing fruits, vegetables and 
fiber(Thomson et al., 2003).  
 
Both polyps and colon cancer occur more frequently due in part to diets of low in fruits, 
vegetables, vegetable protein and fiber.  An extensive meta-analysis has confirmed the 
significant reduced risk for colorectal cancer with high consumption of fruits and 
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vegetables(Riboli and Norat, 2003).  In 1993, Burkitt proposed that high fiber intake 
could be protective for colon cancer, based on the very low rate of this malignancy 
observed in Africa, where high quantities of fiber were consumed in their 
population(Burkitt, 1993). The strongest evidence was from a multinational European 
Study among 500 000 persons, which demonstrated a significant reduced risk for 
cancer in those having the highest fiber intake(Bingham et al., 2003). Similarly, in 
large United State screening study showed dietary fiber, independently of source was 
significantly associated with a reduced risk for colonic adenoma(Peter et al., 2003). 
 
Increased intake of fiber, on the other hand, shortens the intestinal transit time, which in 
turn reduces the exposure of the colon and rectum epithelium to mutagens present in 
the stool. However, fiber supplementation in form of vitamins was not recommended as 
a chemopreventive to decrease the risk of colorectal cancer. There is no evidence of 
benefit(Wilkins and Reynolds, 2008).  
 
Epidemiologic data from 27 countries showed a strong correlation between colorectal 
cancer incidence and average per capita meat consumption(Ognjanovic et al., 2006). 
This is supported by the consensus of the World Health Organization which concluded 
that the high consumption of red meat increases the colorectal cancer risk(Scheppach et 
al., 1999). This finding is consistent with a systematic review that reports an increased 
risk of colorectal cancer in those in the highest red and processed meat consumption 
categories compared with the lowest(Norat et al., 2002). High red meat intake is also 
associated with colonic adenomatous polyps(Yoon et al., 2000). 
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There have been several biologic explanations for this apparent association.  Meat 
contains a substance called creatine and heme iron. High amount of heme iron can be 
cytotoxic and cause hyperproliferative  of colonic mucosa(Cross et al., 2003).  High 
temperature cooking methods used by grilling, frying and charring of high protein 
foods have been associated with increased colon cancer risk.  At high temperatures, 
creatine reacts with amino acids to form heterocyclic aromatic amines which are potent 
mutagens, formed on the surface of beef, chicken and fish when these foods are 
exposed to high temperatures(Nowell et al., 2002).  
 
In addition to that, consistent intake of processing meat has also been associated with 
an increased risk for large bowel cancer. These contain nitrites, which reacts with 
amino acids to form nitrosamines, another class of cancer-causing chemical(Franceschi 
et al., 1998).  
 
A diet high in saturated animal fat, particularly dairy products and red meat  increases 
colorectal cancer risk. The digestion of fats requires the activity of normal bile acids 
that irritate and damage cells lining of the colon. Consequently, bile acids activate 
factors associated with abnormal growth of these cells, resulting in an increased risk of 
colorectal cancer(Glinghammar et al., 1999). 
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For micronutrients such as folate, calcium and vitamin A, C, D, and E, there are still 
limited evidence to support the protective action against colorectal cancer(World 
Cancer Research Fund international, 2011). Their anticarcinogenic roles seem to be 
minor, acting on the intraluminal contest and by strengthening the resistance of the 
large bowel epithelium to carcinogens and by correcting genetic damage(Thomson et 
al., 2003). Furthermore, it was not recommended for the use of vitamin and mineral 
supplements as a prevention to colorectal cancer. Those supplements did not replace or 
add to the benefit of eating fruits and vegetables. Although, we could not rule out the 
benefits of supplements such as improved quality of life but the concern on their long 
term safety  still in doubt(Emma, 2011).   
 
2.1.2.2 Obesity 
There is a consistent association between Body Mass Index (BMI) and risk of 
colorectal cancer. A systematic review(Bergstrom et al., 2001) identified 19 papers 
which consist twelfth cohort and seven case-control studies that evaluated the 
association between BMI and risk of colorectal cancer with fifteen reporting a 
statistically significant positive relationship. Overall there was a 1.03 relative risk (RR) 
of colorectal cancer for every unit increase in BMI. A similar association exists 
between waist to hip ratio and colorectal cancer risk. In a Framingham study, a large 
waist circumference was associated with RR for colon cancer of 4.4 for middle age 
adult and 3.0 for older sedentary adults(Moore et al., 2004). Another recent study also 
had a similar finding. Indeed, this finding  suggests measures of central adiposity was 
more informative for risk of colon cancer than  BMI alone(Pischon et al., 2006). 
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2.1.2.3 Smoking 
Cigarette smoking has been shown to be a significant risk factor for colorectal Cancer 
particularly long term smoking(Tsong et al., 2007). It  has been  estimated that 20% of 
colorectal cancer  in men and 15% in women may be associated with 
smoking(Heineman et al., 1994). Thus, the results of a recent study suggest that 
smokers presented with colorectal cancer at a younger age than nonsmokers(Zisman et 
al., 2006). There were multiple studies estimated the number of years of tobacco use 
required to increase the risk for large and advanced adenomas. Therefore,  a study 
suggests that it may take 25 years for the risk of advanced adenomas to be 
increase(Giovannucci, 2004).  A recent study showed patients who have smoked more 
than 30 pack-years had a more than two fold increase for significant colorectal 
neoplasia as compared with nonsmokers(Anderson et al., 2009). 
 
 
2.2 Colorectal cancer symptoms 
Actually, once the symptoms develop it seems that survival is determined by the 
invasive nature of each tumor and cannot be related to the duration of 
symptoms(Terhaar Sim Dreste et al., 2010). However, the delay in diagnosis and 
treatment may be a particular disadvantage to those patients in whom emergency 
surgery becomes necessary. Emergency surgery is associated with hospital mortality of 
10% whilst elective surgery carries a mortality of only 3.5%(Sio et al., 2009). 
Therefore early recognition of symptoms has a role in improving colorectal cancer 
mortality. 
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A study showed early education of patients about breast cancer has lead to early 
consultation. However, this would be difficult to achieve for colorectal cancer, since 
most people experience minor variations in bowel habit. According to a study among 
200 colorectal cancer patients, ninety nine patients were ignorant of the implications of 
their symptoms and sixty six patients did not regard them as being serious. About 30% 
of patients thought they had piles(Holiday and Hardcastle, 1979).   Furthermore, though 
rectal bleeding and alteration in bowel habit carry an increased risk of distal neoplastic 
lesions, most lesions are detected among asymptomatic subjects. This finding suggests 
that screening represents the optimal strategy to detect CRC or large adenomas in the 
distal colon in the targeted age range. 
 
 
2.3 Population screening 
Screening is a process of identifying a disease or pre disease condition in a person 
without signs or symptoms, considered as healthy individuals. A Screening test did not 
provide a definitive diagnosis. Instead, they help stratify screened subjects into those 
who are likely to have disease and those at higher risk are then candidates for further 
diagnostic testing. Ideally, a screening test should be cheap, safe, quick, well accepted 
and well tolerated.  
 
Average risk group is defined as asymptomatic persons who are 50 years of age 
without family history or other diseases known to increased risk of colorectal 
cancer(Paul et al., 2006). In this population, the only factor indicating risk is age.  
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Colorectal cancer is in increasing trend and is expected to become the first cause of 
death in Asia. There is strong evidence that population screening and early treatment 
reduces colorectal cancer mortality(Pignone et al., 2002). Reports from the American 
Cancer Society, where colorectal cancer screening program have been implemented, 
showed that the incidence has decreased in two straight years and this has been largely 
attributed to the remarkable success of screening programs for colonic polyps and 
colorectal cancer in the United State. 
 
 The screening was increased from 38% in year 2000 to 53% in year 2008(Ahmedin et 
al., 2008). A recent meta-analysis of studies evaluating screening using fecal occult 
blood tests estimated the mortality reduction to be 15% to 33%(Hewitson et al., 2007).
 
The UK Flexible Sigmoidoscopy Trial is examining the efficacy of a single Flexible 
Sigmoidoscopy screen offered to asymptomatic individuals aged 55 to 64 years, and 
data on the effect on mortality showed 43%  reduction  and confers a substantial and 
long lasting benefit(Atkin et al., 2010). 
 
Subsequently, as the biology of colorectal cancer has a latern phase, where most of it 
develops from benign polyps over a period of several years, it provides a window of 
opportunity to intervene(Paul et al., 2006). Furthermore, the cancer development 
process consists of multiple step, from polypoid adenomas to  shedding of cell 
component and occult bleeding which is presymptomatic or preclinical phase that are 
potentially detectable by appropriate screening techniques(Paul et al., 2006). Therefore, 
screening is an ideal strategy, as the detection and removal of premalignant lesions can 
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prevent the subsequent development of colorectal cancer.  Thus, surgical resections of 
pre cancerous stage or early stage of colorectal cancer offer a chance of cure(Jaffer et 
al., 2005).  
 
In fact, all standard options for colorectal cancer screening in average-risk individuals 
are cost effective compared to cost of treating the colorectal cancer(U.S.Preventive 
Services Task Force, 2008). They are as cost-effective as mammography(Frazier et al., 
2000). The cost of treating colorectal cancer is significantly high. According to 
National Cancer Institute in United State, it is estimated that the direct medical 
expenditure annually approached $ 6.5 billion. This was second in cancer treatment 
costs only to breast cancer, at $6.6 billion per year(National Cancer Institute, 2010). 
 
2.3.1 Screening tools 
The recognized standard examinations for colorectal cancer screening have included 
digital rectal examination, fecal occult blood test (FOBT), sigmoidoscopy, double 
contrast barium enema and colonoscopy. 
 
Digital rectal examination is generally no longer recommended as a colorectal cancer 
screening because alone it has not proven effective. The seven to eight centimeter reach 
of the examining finger could detect at best only 10% of colorectal cancers.  
Nonetheless, digital rectal examination remains a part of sigmoidoscopy, colonoscopy 
and barium enema examination(Paul et al., 2006). 
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Fecal Occult Blood Test checks for occult or hidden blood in the stool.  The 
effectiveness of fecal occult blood test has been established. Evidence from several 
randomized controlled trials suggests that annual or biennial fecal occult blood test 
(FOBT) screening reduces mortality by 16 percent to 33 percent (Kronborg et al., 1996; 
Mandel et al., 2000).  
 
Although the use of annual fecal occult blood test with a lower sensitivity has been 
demonstrated to reduce both colorectal cancer cases and colorectal cancer mortality, the 
number of life years gained will be greater using higher sensitivity test(U.S.Preventive 
Services Task Force, 2008). 
 
High sensitivity fecal occult blood test means the test with sensitivity more than 70%  
and its specificity more than 90%. Currently the available tests that meet both 
specifications include SENSA guaiac testing and fecal immunochemical 
tests(U.S.Preventive Services Task Force, 2008).  
 
 
FOBTs are based on two principal techniques, Guaiac tests and immunochemical test. 
The Guaiac test is a conventional stool test for stool occult blood. For accurate test 
results, it required 3 different days sample from bowel movement with a strict diet. For 
three days before stool collection period, they have to avoid red meat, vitamin C, citrus 
fruits and juices. 
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The Guaiac test used a chemical method that was designed to detect fecal hemoglobin 
via the oxidize chromogenic material in the presence of hydrogen peroxide. The 
chemical test may give rise to a false positive when reacts with dietary fresh vegetable 
components which posses peroxidase-like activity, as well as with hemoglobin 
contained in meat, myoglobin or bleeding from benign lesions (David et al., 2008). 
Hence, high false positive rate leads to unnecessary anxiety and unnecessary 
performance of invasive tests. 
 
 
 Despite that, FOBT can also lead to false negative result. Diet contains vitamin C will 
inhibit the peroxidase reaction caused false positive result. (David et al., 2008). In case 
of a negative FOBT, it could falsely reassure patients and lead to delay response to the 
development of colorectal symptoms. Therefore, dietary restrictions are mandatory to 
ensure accurate tests for fecal occult blood.  
 
 
To overcome this problem, fecal immunochemical test has been introduced. Recently, 
fecal immunochemical tests for hemoglobin have been shown to be more sensitive than 
the guaiac test for cancer and adenomas(Hoepffner et al., 2006). Immunological fecal 
occult blood test uses immunochromatography technique to detect human hemoglobin. 
The sensitivity was around 69%  to 88% and the specificity was 99%(Lohsiriwat et al., 
2007). The test was not interfering with the dietary intake. Immunochemical stool tests 
are more expensive than guaiac-based tests, but it has the potential to be more cost 
effective if fewer colonoscopies are needed for post screening follow-up. Fecal occult 
blood test is more practical as primary screening tool since the test is non invasive, 
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inexpensive and can been rolled out in the community without much involvement from 
the hospital setting. 
 
 
For double-contrast barium enema (DBCE), a series of X-rays of the entire colon and 
rectum are taken after the patient is given an enema with barium solution and air is 
introduced into the colon. The barium and air help to outline the colon and rectum on 
the   X-rays. The use of barium enema as a screening tool has been considered to be 
cost effective(Winawer S et al., 2003). Furthermore, the procedure rarely cause 
complication and it does not require any sedation. However, the consequences of 
repeated radiation dose are unclear, but are of concern(Sung et al., 2008). In addition, it 
has lower sensitivity where the test may not detect some small lesions and does not 
permit removal of polyps or biopsy of the lesion. In the National Polyps Study, DCBE 
detected only 53% of adenomatous polyps six to ten mm in size and 48 percent of those 
more than ten mm in size compared with colonoscopy(Winawer et al., 2000). Because 
of its lower sensitivity, the Asian Pacific Consensus Group does not recommend DCBE 
as a first-line option for colorectal screening in average risk group(Sung et al., 2008). 
 
 
As approximately three-quarters of all colorectal cancers are in the rectum or sigmoid 
colon, it seems reasonable to use flexible sigmoidoscopy with a 60 cm instrument as a 
screening tool, particularly as the finding of a significant distal adenoma may act as an 
index of proximal disease. Based on these premises it has been proposed flexible 
sigmoidoscopy as an effective modality for colorectal cancer screening(Atkin et al., 
2001).  Sensitivity of this test varies from 73.3% for small polyps to 96.7% for cancer 
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and large polyps and the specificity ranges from 92% for small polyps to 94% for 
cancer and large polyps. 
 
 
Screening by flexible sigmoidoscopy appears to be safe, the bowel perforation rate is 
only  1 in every 5000 procedure and complications associated with biopsy and 
polypectomy are unlikely if the bowel has been prepared or carbon dioxide 
insufflations is available(David et al., 2008). The examination can be conducted 
without sedation and with only enema preparation, rather than taking an oral bowel 
preparation. 
 
  
However, the limitations of flexible sigmoidoscopy include the length of the scope. 
Since up to two thirds of proximal advanced lesions in Asians are found in the absence 
of distal lesions, it creates a false sense of security using flexible sigmoidoscopy for 
screening. 
 
 
Colonoscopy appears to be the most effective screening tool. A colonoscopic 
examination provides better visualization of the entire rectum and colon. Because of 
that it can be considered as a gold standard test for colorectal cancer screening.  It’s 
also had the advantages of removing the polyps and biopsy during the procedure itself.  
The sensitivity is ranging between 78.5% to 96.7%, and it’s specificity is 
98%(Markowitz and Winawer, 1999). 
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However the procedure is not without risks and complications. Furthermore, it is also 
costly.  In a study of 16318 individuals age 40 years and older undergoing colonoscopy 
between 1994 to 2002, the rate of serious complications was 0.5% with perforations 
occurred in 0.09% of  colonoscopies(Levin et al., 2006). However, the benefit of 
colonoscopy must also be measured against risk of perforation and procedure-related 
deaths. 
 
 
In addition, colonoscopy is an operator dependent procedure. A study done comparing 
colonoscopies with mean withdrawal times of less than six minutes to those with 
withdrawal times of six minutes or more shows those with withdrawal times longer had 
higher rates of detection of any neoplasia. Thus,  it also has been shown that 15% to 
27% of adenomas were missed by a single colonoscopy and 6 % of adenomas larger 
than one centimeter were missed(Hixson et al., 1991). 
 
 
In recent years, some groups have also proposed newer screening technologies such as 
stool DNA and computed tomographic colonography (CT)(Smith et al., 2009). Virtual 
colonoscopy refers to examination of computer-generated images of colon constructed 
from data obtained in an abdominal CT examination. These images simulate the effect 
of an optical colonoscopy. A bowel preparation is required to cleanse the bowel before 
examination, and the colon insufflated with carbon dioxide by insertion of rectal tube.  
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The performance of virtual colonoscopy depends heavily on the size of the lesion. The 
accuracy of detection is also a reflection of the experience and training of the 
radiologist. A study done in asymptomatic adults underwent same day CT and optical 
colonoscopy showed virtual colonoscopy performed with excellent techniques compare 
favorably with optical colonoscopy. The sensitivity of virtual colonoscopy for 
adenomatous polyps was 93.8% for polyps at least 10 mm in diameter, 93.9% for 
polyps at least 8 mm and 88.7% for polyps at least 6 mm in diameter. The sensitivity of 
optical colonoscopy was 87.5%, 91.5% and 92.3% for the three polyps respectively. 
The specificity of virtual colonoscopy was 96%, 92.2% and 79.6% 
respectively(Pickhardt et al., 2003). 
 
 
Fecal DNA testing is promoted as a more accurate, non invasive alternative to FOBT 
for CRC screening. Briefly, many DNA mutations have been identified that are 
associated with the progression from normal colonic mucosa to adenomatous polyps 
and finally carcinoma. Recent advances in technology allow human DNA to be 
separated from bacterial DNA in the stool, amplified more than a billion fold by 
polymerase chain reaction (PCR), and then tested for mutations associated with 
colorectal neoplasia. The sensitivity of the test to detect colorectal cancer was 52% and 
specificity was 95%(Imperiale et al., 2004). In a more recent study using two markers, 
the sensitivity of the test  increased to 87.5%(Itzkowitz et al., 2006). 
 
 
 
